The peptide is functionally degraded beyond useful application for most protocols
You have a triple agonist with the strongest single-compound weight-loss record in modern obesity research, plus an amylin analog with a standalone double-digit result and a phase 3 combination precedent proving amylin adds to GLP-1
Important considerations: BPC-157 is sold for research purposes only and is not intended for human consumption No human clinical trials have established safety or efficacy Quality and purity of research peptides vary significantly between suppliers Individual responses may differ significantly from research findings Always consult with a qualified healthcare provider before considering any peptide research This content does not constitute medical advice, diagnosis, or treatment recommendations The decision to use any research compound is a personal one that should be made with full awareness of the legal status, limited human data, and potential risks involved
The concept of "normal" is based on the middle 95% of results, fitting within a typical bell-shaped curve
How GHK-Cu Compares to Retinoids, Vitamin C, and Other Anti-Aging Ingredients The 1998 head-to-head trial by Abdulghani measured procollagen synthesis side by side, and the copper-binding peptide outperformed both vitamin C and tretinoin
